SOLIGENIX, INC. SNGX Cash Flow

Soligenix, inc. (SNGX)

CashFlow / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Operating activities:
Net loss
-15,297	-9,355	-9,588	-8,729	-8,162	-8,899	-7,934	-7,035	-7,790	-7,147	-5,338	-6,048	-3,829	-3,245	-4,973	-526	-4,411	-7,831	-3,849	-10,973	-7,944	-6,706	-7,636	-9,846	-12,303	-10,058	-12,037	-6,236	-3,811	-4,163	0	0	0	-	-	-	-
Adjustments to reconcile net loss to net cash used in operating activities:
Net loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0
Amortization and depreciation
60	54	48	44	44	44	44	51	58	68	79	84	88	89	130	171	210	247	246	244	243	245	242	238	235	230	229	235	229	230	233	229	231	226	0	0	0
Non-cash lease expenses
126	123	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of discount on debt
-	-	-	-	-	-	-	-	-	-	-	-	-	7	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of discount on debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restricted stock issued to employee
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	0	0	0
Restricted stock issued to vendors
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-
Share-based compensation
360	376	352	334	352	380	423	447	451	489	449	478	585	574	694	711	648	654	675	701	685	720	690	936	900	803	650	391	424	462	568	562	676	715	0	0	0
Issuance of common stock for milestone
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Issuance of common stock for services
160	159	0	0	0	-	0	0	0	5	5	21	58	52	94	149	130	232	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Issuance of common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Change in fair value of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-1,541	-814	-5,038	-2,569	1,201	-2,732	523	-2,166	-3,436	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Restricted common stock issued to vendors
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-
Warrants issued to vendor
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-4	0	0	0	-	0	0	0	-	-	-	-	-	-	-	-
Change in fair value of warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-
Change in operating assets and liabilities:
Contracts and grants receivable
-263	-182	-129	144	278	275	363	815	-166	-280	-1,062	-1,090	-29	-778	-167	1,072	677	1,190	526	268	-348	-72	1,176	274	37	527	-76	-49	332	-23	-59	-96	155	241	0	0	0
Prepaid expenses and other current assets
60	452	168	26	52	-105	300	-6	21	128	-105	-99	47	-109	67	-14	-42	71	-47	180	33	37	7	-131	-73	-5	-11	-55	26	-55	54	158	49	8	0	0	0
Research and development incentives receivable
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income tax receivable
0	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income tax receivable
-	-	-	-	-	-	0	0	0	416	0	0	0	-	-	-	-	-	-	-	-	-750	0	0	0	750	0	0	0	-	-	-	0	-	-	-	0
Operating lease liability
-125	-121	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue
-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable and accrued expenses
2,423	1,968	1,775	1,949	481	1,019	1,081	182	940	382	-1,627	-1,083	-1,822	-1,475	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accounts payable
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	670	991	1,483	1,844	600	-99	395	190	145	421	-179	-348	-154	-187	-370	0	0	0
Accrued compensation
13	3	-24	-5	-17	-38	-75	-1	-124	-22	76	1	137	56	14	8	3	-16	-11	-22	-13	81	4	-206	21	204	27	205	-92	-99	-13	22	82	-107	0	0	0
Total adjustments
7,385	1,846	2,046	2,277	83	1,655	1,046	-96	1,447	636	-279	438	-2,141	-1,737	81	-3,496	-106	2,444	-569	5,891	4,359	4,240	4,245	5,736	8,202	5,602	8,531	3,715	1,107	1,527	594	1,139	1,145	426	0	0	0
Net cash used in operating activities
-7,911	-7,509	-7,541	-6,451	-8,078	-7,244	-6,887	-7,131	-6,343	-6,510	-5,617	-5,609	-5,971	-4,982	-4,892	-4,022	-4,518	-5,386	-4,419	-5,082	-3,585	-2,466	-3,390	-4,110	-4,100	-4,456	1,764	2,749	2,566	2,635	-3,515	-6	-951	-1,951	0	0	0
Investing activities:
Acquisition of intangible assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	151	0	0	0
Purchases of office furniture and equipment
0	-	-	-	-	1	26	26	26	26	2	2	5	7	7	15	14	22	25	22	42	50	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in investing activities
0	-	-	-	-	-0	-26	-26	-26	-26	-2	-2	-5	-7	-7	-15	-14	-22	-275	-272	-292	-300	-54	-53	-37	-17	0	0	0	-	-	-	-	-152	0	0	0
Financing activities:
Proceeds from issuance of common stock pursuant to FBR At Market Issuance Sales Agreement
7,609	4,142	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Costs associated with FBR At Market Issuance Sales Agreement
273	132	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from the exercise of warrants
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Stock issuance costs associated with equity line purchase agreement
-	-	-	-	-	-	-	-	-	-	-	-	-	-	41	212	190	171	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net proceeds from issuance of common stock pursuant to public financing
-	-	-	-	-	-	0	0	19	-	0	0	0	-	-	-	-	0	1,615	1,271	558	470	0	0	0	-	-	0	0	-	-	-	-	0	0	0	0
Principal repayment - financing lease
6	6	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Proceeds from exercise of options and warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	253	0	0	0
Net cash provided by financing activities
8,015	4,005	2,387	9,194	8,908	8,423	13,636	5,589	5,593	5,573	4,963	8,242	8,859	8,840	6,521	3,186	3,780	4,804	4,518	4,348	3,283	2,436	1,072	1,077	7,132	6,974	0	0	0	-	-	-	-	649	0	0	0
Effect of exchange rate on cash and cash equivalents
-69	-34	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease) in cash and cash equivalents
3	-3,563	-5,168	2,741	832	1,174	6,720	-1,568	-775	-963	-656	2,630	2,883	3,851	1,621	-852	-752	-603	-176	-1,005	-594	-331	-2,372	-3,086	2,994	2,499	2,884	3,696	-2,709	-2,640	-3,519	274	-627	-1,455	0	0	0
Supplemental information:
Reclassification of warrant liability to additional paid-in capital
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	2,557	2,557	3,096	2,202	1,055	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-
Cash paid for lease liabilities:
Operating lease
140	140	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Financing lease
8	8	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non-cash investing and financing activities:
Deferred issuance costs reclassified to additional-paid-in capital
47	33	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Issuance of stock options, cash exercise price received December 2019
0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Present value of right-of-use assets and lease liabilities recognized on January 1, 2019
-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued software development cost
-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred issuance costs included in accounts payable
-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-